The authors showed that treatment of mice with recombinant adenoviruses to overexpress GDNF ameliorated dextran sulfate sodium (DSS)-induced colitis, improved colonic transit defects, and in vitro IEC healing responses (30–32). The gene discussed is GDNF; the disease is colitis.